About
Oncoliq develops a multi-cancer early detection liquid biopsy test based on microRNA analysis and machine learning to enable early, non-invasive, low-cost cancer detection and patient follow-up.
Explore Oncoliq's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.